Loading...
Loading...
- Berkeley Lights Inc BLI reports Q2 sales of $19.3 million, +82% Y/Y, but slightly missing the consensus of $19.64 million.
- The Company expanded the installed base to 92 platforms, with seven new direct placements shipped in the quarter. The gross margin remains unchanged at 66%.
- It reported a wider operating loss of $(17.8) million, compared to $(12.2) million a year ago.
- Net loss swelled to $(18.1) million, compared to $(12.4) million in Q2 FY20.
- EPS loss of $(0.27) versus $(4.25) a year ago, missed the consensus of $(0.24).
- Berkeley Lights continues to expect full-year 2021 revenue of $90 million - $100 million, a Y/Y growth of 40% - 56%.
- Separately, Berkeley has announced a multi-year agreement with Bayer AG BAYRY to develop and perform high-throughput functional screening workflows to accelerate and expand the discovery of novel traits.
- The terms of the agreement were not disclosed.
- Berkeley Lights will leverage its platform to screen individual bioactive variants for Bayer, marking the first application of Berkeley Lights' technology for use in the agricultural sector.
- Price Action: BLI shares are down 4.09% at $42 premarket on the last check Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in